Anti-EMAP II ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a humanized anti-EMAP II antibody shows reduced immunogenicity and increased half-life while having similar or improved antigen binding capacity compared to the parent monoclonal antibody. Thus, the humanized anti-EMAP II antibody can be more effectively used as a diagnostic reagent for EMAP II and a therapeutic agent for diseases that are mediated by EMAP II.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-327MZ | Human Anti-EMAP II Recombinant Antibody (TAB-327MZ) | ELISA | Humanized antibody |
TAB-327MZ-S(P) | Human Anti-EMAP II Recombinant Antibody; scFv Fragment (TAB-327MZ-S(P)) | ELISA | Humanized scFv |
TAB-327MZ-F(E) | Human Anti-EMAP II Recombinant Antibody; Fab Fragment (TAB-327MZ-F(E)) | ELISA | Humanized Fab |
There are currently no Customer reviews or questions for AFC-217CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.